معرفی
David Feola is a Professor and Assistant Dean of Graduate Studies at the University of Kentucky College of Pharmacy. He holds dual degrees (PharmD and PhD) from the same institution. His research focuses on immunology and infectious disease pharmacotherapy, particularly exploring macrophage activation states in chronic inflammatory diseases like pulmonary fibrosis and myocardial infarction. He leads a translational research program using mouse models and clinical studies in cystic fibrosis patients to identify therapeutic targets.
Dr. Feola's education includes a Doctor of Pharmacy and PhD in Clinical Pharmaceutical Sciences from the University of Kentucky, followed by PGY1 and PGY2 residencies in pharmacy practice and infectious diseases. His work emphasizes azithromycin's immunomodulatory effects, demonstrating its role in polarizing macrophages to an M2 phenotype to reduce inflammation and tissue remodeling. He collaborates on projects involving spinal cord injury, myocardial infarction, and Alzheimer’s disease.
As Assistant Dean of Graduate Studies, he innovates graduate education through cutting-edge training methods. His lab investigates nanomaterials (e.g., cerium dioxide) and liposomal drug delivery systems to enhance therapeutic outcomes. Despite no explicitly mentioned awards, his prolific publication record and leadership roles highlight his contributions to pharmaceutical sciences and academia.
Dr. Feola teaches in the Doctor of Pharmacy Program and supports clinical services at UK Chandler Medical Center. His grants and collaborations include interdisciplinary projects with UK and external institutions, focusing on inflammation modulation and drug repurposing strategies for chronic diseases.
His research lab focuses on macrophage biology with applications to pulmonary, cardiovascular, and neurodegenerative disorders. Future work aims to advance personalized approaches in anti-inflammatory therapies and refine educational frameworks for pharmaceutical scientists.
